
Vemlidy Coupons & Savings Card – Discount Prices from $1476.12
My prescription
Edit
25MG, Vemlidy (30 Tablets)
Select pharmacy

Albertsons
$1476.12
COUPON PRICE
Walgreens
$1638.70
COUPON PRICE
Walmart
$1685.65
COUPON PRICEVemlidy savings card
Show this card to your pharmacist
Albertsons
$1476.12
BIN
ID
PCN
GRP
015995
LHKPY242504
GDC
DR33
Powered by
Related nucleotide polymerase / NS5A inhibitor combinations prescriptions
More prescriptions for hepatitis B
Related nucleotide polymerase / NS5A inhibitor combinations prescriptions
More prescriptions for hepatitis B
Price history for Vemlidy
30 Tablets, 25MG
Average retail price for Vemlidy
Average SaveHealth price for Vemlidy
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Vemlidy dosage forms
Dosage Quantity Price from Per unit 25MG 30 Tablets $1573.01 $52.43
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 25MG | 30 Tablets | $1573.01 | $52.43 |
What is VEMLIDY used for?
VEMLIDY is used for the treatment of chronic hepatitis B virus (HBV) infection in adults with compensated liver disease.
How much does VEMLIDY cost?
The cost of VEMLIDY can vary depending on factors such as the pharmacy, location, insurance coverage, and any available discounts or assistance programs. It is recommended to check with local pharmacies or consult with a healthcare provider or insurance company for the most accurate and up-to-date pricing information.
What is the success rate of VEMLIDY?
Vemlidy (tenofovir alafenamide) has shown high efficacy in the treatment of chronic hepatitis B virus (HBV) infection. Clinical trials have demonstrated that a significant percentage of patients achieve viral suppression, with many studies reporting success rates of over 90% in terms of reducing HBV DNA levels to undetectable levels. Additionally, Vemlidy is associated with improvements in liver function tests and has a favorable safety profile. However, individual responses can vary, and it is important for patients to discuss their specific situation with their healthcare provider.
Does VEMLIDY cause weight loss?
Weight loss is not commonly reported as a side effect of VEMLIDY (tenofovir alafenamide). However, if a patient experiences unexpected weight changes while taking this medication, it is advisable to consult with a healthcare provider to rule out any underlying issues or to discuss any concerns.
When will VEMLIDY go generic?
As of the latest information available, VEMLIDY (tenofovir alafenamide) is still under patent protection. The patent for VEMLIDY is expected to expire in 2032, which is when a generic version might become available, subject to regulatory approvals and any potential patent litigation.
